This is because it includes all atherogenic lipoproteins, which can lead to the development of atherosclerosis, a major cause of heart attacks and strokes. A high non-HDL cholesterol level means a person has high “bad” cholesterol levels A hraltin their blood. This can increase the risk of developing certain conditions, such as heart disease, heart attack, and stroke. A person whose cholesterol results fall outside typical ranges should talk with a healthcare professional.

However, a doctor may set different cholesterol target goals for individuals. A healthcare professional may recommend a lower target if a person has specific conditions, such as a history of heart attack, stroke, or heart disease risk factors. A lipid panel is a blood test that shows your total cholesterol levels. As previously mentioned, LDL is “bad” cholesterol and https://p1nup.in/ HDL is “good” cholesterol, but keep an eye on triglyceride levels because they also put you at higher risk of heart disease. Non-HDL cholesterol is a key indicator of cardiovascular risk, particularly for individuals with elevated cholesterol levels.

A person can only determine if they have high cholesterol by taking a lipid profile test. Even with optimal LDL-C, residual atherogenic particles may persist. Foods high in saturated and trans fats can increase non-HDL cholesterol. Examples include fatty beef, lamb, pork, saturated vegetable oils, and commercially fried foods. The typical range of non-HDL cholesterol for anyone ages 19 and younger is under 120 mg/dL. For those ages 20 and above, the typical range of non-HDL cholesterol is under 130 mg/dL.

• A healthcare professional may recommend a lower target if a person has specific conditions, such as a history of heart attack, stroke, or heart disease risk factors.
• A high non-HDL cholesterol level means a person has high “bad” cholesterol levels A hraltin their blood.
• Diets rich in unsaturated fats (like olive oil, fatty fish, and nuts), fiber, and lean protein improve lipid metabolism.
• The word atherogenic refers to the potential of certain substances—like specific lipoproteins—to promote atherosclerosis, the slow buildup of fatty deposits in artery walls.

One reason for this is that the LDL level reported on your blood test is not actually measured in the lab. The findings support the idea that doctors should look beyond LDL and pay closer attention to non-HDL-C and ApoB when managing cardiovascular risk. A major analysis published in 2025 looked at results from multiple clinical trials involving different cholesterol-lowering treatments—such as statins, ezetimibe, and PCSK9 inhibitors.

Diet

Despite its growing clinical relevance, non-HDL-C is often left unflagged unless it exceeds a high threshold—typically around 160 mg/dL (4.1 mmol/L). Yet for many patients, especially those at elevated cardiovascular risk, that’s far too lenient. The higher the non-HDL cholesterol, the higher the risk of heart disease. Calculate the ratio of triglycerides to HDL cholesterol to evaluate cardiovascular risk. In sum, non-HDL-C and remnants are modifiable through lifestyle and often respond more readily than LDL-C.

Embed this calculator

The word atherogenic refers to the potential of certain substances—like specific lipoproteins—to promote atherosclerosis, the slow buildup of fatty deposits in artery walls. When these deposits grow, they can narrow or block blood flow, setting the stage for heart attacks or strokes. This article discusses non-HDL cholesterol, what it includes, and its typical range. It also explores other indicators of cholesterol levels, and the levels that health experts consider typical. Current cholesterol guidelines recommend a non-HDL cholesterol level of 30 mg/dL higher than your desired LDL cholesterol level. As an example, if you’d like to lower your LDL to 100 mg/dL, your non-HDL goal should be 130 mg/dL.

This adjustment accounts for the atherogenic particles beyond LDL—remnants, VLDL, IDL, and others—that contribute meaningfully to residual risk. Cholesterol readings are generally helpful in providing an overview of a person’s general health. However, many experts find non-HDL cholesterol a more reliable measure of someone’s heart disease risk.

For example, if your total cholesterol is 220 mg/dL (5.7 mmol/L) and HDL-C is 50 mg/dL (1.3 mmol/L), your non-HDL cholesterol is 170 mg/dL (4.4 mmol/L). What remains represents cholesterol in LDL, VLDL, IDL, lipoprotein(a), and remnants—key drivers of plaque buildup. Our body makes up all or most of the cholesterol we need to stay healthy, so we don’t need to consume too much in our diet.

That makes them not just powerful risk markers, but also promising treatment targets through everyday interventions. And it applies whether you’re screening for risk, titrating statins, or chasing residual risk in complex patients. Every atherogenic lipoprotein particle — whether it’s an LDL, VLDL, IDL, Lp(a), or chylomicron remnant — carries exactly one ApoB molecule. That makes ApoB a direct measure of particle number, a kind of headcount for the agents of atherosclerosis. A 2024 study from the Swedish SWEDEHEART registry examined over 56,000 patients who had experienced a myocardial infarction and tracked their outcomes for a median of 5.4 years. Researchers focused on non-HDL cholesterol (non-HDL-C) levels, analyzing how both early reduction (at 2 months) and sustained control (at 1 year) influenced long-term cardiovascular outcomes.

What else do cholesterol tests measure?

For example, if a person has a total cholesterol of 240 mg/dl and an HDL of 40, their non-HDL is 200 mg/dl. Although a lipid test can be done with or without fasting, you are more likely to get accurate results by fasting, especially if your triglycerides are going to be measured. This means you can have nothing but water for nine to 12 hours before the test.

Non-HDL cholesterol refers to all your cholesterol values minus your HDL cholesterol. In essence, it is a measure of the not-so-good cholesterol levels in your body. So, if you have high triglycerides or other risk factors for heart disease, your healthcare provider may want to evaluate your non-HDL cholesterol and discuss your levels with you. A 2024 study demonstrates that elevated remnant cholesterol and triglycerides are strongly linked to an increased risk of developing multiple cardiometabolic conditions over time.

Low-Density Lipoprotein

Your non-HDL cholesterol is determined by subtracting your HDL cholesterol from your total cholesterol. Send detailed event messages in WhatsApp group chats that include the date, time, and venue. Ensure everyone in the group chat feels invited to the party, no matter what phone they use. In contrast, the value of non-HDL cholesterol is based on a simple and reproducible calculation (total cholesterol minus HDL cholesterol). With end-to-end encryption, your personal messages and calls are secured across different phones.

• Optimal HDL levels are 40 mg/dL for adult men and 50 mg/dL for adult women.
• But, if levels rise too high, it may increase your risk of health problems like heart attack or stroke.
• It calculates all the “bad” types of cholesterol in the body by subtracting HDL, or “good” cholesterol, from a person’s total cholesterol.
• The typical range of non-HDL cholesterol for anyone ages 19 and younger is under 120 mg/dL.

These include low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), intermediate-density lipoprotein, and lipoprotein(a) (Lp(a). Optimal HDL levels are 40 mg/dL for adult men and 50 mg/dL for adult women. Some people inherit defective cholesterol-transporting genes from their parents, a condition called familial hypercholesterolemia that results in abnormally high cholesterol levels. Estimate cardiovascular risk by comparing your total cholesterol to HDL levels and reviewing guideline-based classifications. If your lipid panel includes total cholesterol and HDL-C, the data is already there.

The study found that lowering non-HDL cholesterol and ApoB was more closely tied to reducing heart attack and stroke risk than simply lowering LDL cholesterol alone. This was especially true for people on combination therapy, where targeting multiple lipid markers provided greater protection. This real-world data supports the idea that non-HDL-C is not only a powerful predictor of residual risk but also a practical treatment target. The study reinforces the importance of monitoring and aggressively lowering non-HDL-C—especially in the early months following a heart attack—to improve long-term outcomes.

It represents the total cholesterol minus the high-density lipoprotein (HDL) cholesterol, effectively measuring all the “bad” cholesterol components in the blood. Non-HDL cholesterol includes low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), and other types of cholesterol that can contribute to plaque build-up in arteries. Reducing refined carbohydrates, added sugars, and alcohol intake can sharply lower triglyceride levels and remnant cholesterol. Diets rich in unsaturated fats (like olive oil, fatty fish, and nuts), fiber, and lean protein improve lipid metabolism. Non-HDL cholesterol is considered a more comprehensive measure of cardiovascular risk than LDL cholesterol alone.

In the statin era, where residual cardiovascular events remain stubbornly high, this marker has become increasingly relevant. But the elevated non-HDL-C reflects a blood full of remnant and triglyceride-rich particles that heighten cardiovascular risk. Non-high-density lipoprotein (non-HDL) cholesterol is a way of measuring levels of plaque-causing lipoproteins in the blood.